A twenty-three year old woman who was suffering with systemic juvenile idiopathic arthritis and a disorder known as dysautonomia was treated and cured by infusion of her own adult stem cells. Her quality of life improved as a result of the contribution made by Celltex Therapeutics Corporation, a biotechnology company based in Houston.
Dysautonomia is an autoimmune disease that affects over thirty thousand children in the country. Here is no definite cure for this disease. Sarah Hughes was diagnosed by this disease when she was less than a year old. It caused inflammation and stiffness of joints. She was unable to stand for more than a few minutes and digest her food.
Sarah was on tube feeds before she decided on receiving her own adult stem cells after suffering for twenty two years. Her family did some research on the Celltex Corporation and their proprietary technology that isolates and multiplies a person’s own adult stem cells to use them as a regenerative therapy for autoimmune and degenerative diseases. Sarah received her own adult stem cells with the support of her family as well as her close circle of friends.
Adult stem cells have a striking potential of being able to migrate to several parts of the body and recognize injury or inflammation sites. A person can use the banked stem cells for immune or regenerative therapy through injections and infusions by a licensed doctor. After the infusion, Sarah observed that her appetite became normal and she was feeling more energetic than before.
The key issue is that the FDA has taken a stance that a person’s own stem cells have to be recognized as a drug and cannot be administered until necessary clinical trials have been done before they are regulated.
{{cta(‘3fe0aac7-7562-46dc-b8b9-c706d9cfd6b1’)}}
{{cta(‘fec594e9-5433-4350-9180-2bdd371eb399’)}}